![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/docs/US/2024-04-23/USRE49931E1/abs.jpg.600x600.jpg)
- 专利标题： [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
-
申请号： US17584147申请日： 2022-01-25
-
公开(公告)号： USRE49931E1公开(公告)日： 2024-04-23
- 发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理机构： Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- 优先权： IN 1611022328 2016.06.29
- 主分类号： A61K31/4196
- IPC分类号： A61K31/4196 ; A61K31/437 ; A61K31/4427 ; A61K45/06 ; C07D249/00 ; C07D471/04
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/abs-image/US/2024/04/23/USRE49931E1/abs.jpg.150x150.jpg)
摘要：
Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
信息查询
